134 related articles for article (PubMed ID: 26485928)
21. Cytology specimens offer an effective alternative to formalin-fixed tissue as demonstrated by novel automated detection for ALK break-apart FISH testing and immunohistochemistry in lung adenocarcinoma.
Rosenblum F; Hutchinson LM; Garver J; Woda B; Cosar E; Kurian EM
Cancer Cytopathol; 2014 Nov; 122(11):810-21. PubMed ID: 25099128
[TBL] [Abstract][Full Text] [Related]
22. In situ visualization of gene expression using polymer-coated quantum-dot-DNA conjugates.
Choi Y; Kim HP; Hong SM; Ryu JY; Han SJ; Song R
Small; 2009 Sep; 5(18):2085-91. PubMed ID: 19517489
[TBL] [Abstract][Full Text] [Related]
23. Fluorescence in situ hybridization (FISH) on maize metaphase chromosomes with quantum dot-labeled DNA conjugates.
Ma L; Wu SM; Huang J; Ding Y; Pang DW; Li L
Chromosoma; 2008 Apr; 117(2):181-7. PubMed ID: 18046569
[TBL] [Abstract][Full Text] [Related]
24. Single-step multicolor fluorescence in situ hybridization using semiconductor quantum dot-DNA conjugates.
Bentolila LA; Weiss S
Cell Biochem Biophys; 2006; 45(1):59-70. PubMed ID: 16679564
[TBL] [Abstract][Full Text] [Related]
25. Quantum dot-mediated biosensing assays for specific nucleic acid detection.
Yeh HC; Ho YP; Wang TH
Nanomedicine; 2005 Jun; 1(2):115-21. PubMed ID: 17292066
[TBL] [Abstract][Full Text] [Related]
26. Detection of EBV in nasopharyngeal carcinoma by quantum dot fluorescent in situ hybridization.
Chen HL; Peng J; Zhu XB; Gao J; Xue JL; Wang MW; Xia HS
Exp Mol Pathol; 2010 Dec; 89(3):367-71. PubMed ID: 20858485
[TBL] [Abstract][Full Text] [Related]
27. PGDS, a novel technique combining chromogenic in situ hybridization and immunohistochemistry for the assessment of ErbB2 (HER2/neu) status in breast cancer.
Ni R; Mulligan AM; Have C; O'Malley FP
Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):316-24. PubMed ID: 17721278
[TBL] [Abstract][Full Text] [Related]
28. In Vitro Tracking of Human Umbilical Vein Endothelial Cells Using Ultra-Sensitive Quantum Dot-Embedded Silica Nanoparticles.
Kim J; Lee S; Lee YK; Seong B; Kim HM; Kyeong S; Kim W; Ham K; Pham XH; Hahm E; Mun JY; Safaa MA; Lee YS; Jun BH; Park HS
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982869
[TBL] [Abstract][Full Text] [Related]
29. Fluorescence In Situ Hybridization with Quantum Dot Labels in E. coli Cells.
Liu Y; Han Z; Sarkar S; Smith AM
Methods Mol Biol; 2021; 2246():141-155. PubMed ID: 33576988
[TBL] [Abstract][Full Text] [Related]
30. Direct in situ hybridization with oligonucleotide functionalized quantum dot probes.
Bentolila LA
Methods Mol Biol; 2010; 659():147-63. PubMed ID: 20809309
[TBL] [Abstract][Full Text] [Related]
31. Oriented Bioconjugation of Unmodified Antibodies to Quantum Dots Capped with Copolymeric Ligands as Versatile Cellular Imaging Tools.
Tasso M; Singh MK; Giovanelli E; Fragola A; Loriette V; Regairaz M; Dautry F; Treussart F; Lenkei Z; Lequeux N; Pons T
ACS Appl Mater Interfaces; 2015 Dec; 7(48):26904-13. PubMed ID: 26551755
[TBL] [Abstract][Full Text] [Related]
32. Combining M-FISH and Quantum Dot technology for fast chromosomal assignment of transgenic insertions.
Yusuf M; Bauer DL; Lipinski DM; MacLaren RE; Wade-Martins R; Mir KU; Volpi EV
BMC Biotechnol; 2011 Dec; 11():121. PubMed ID: 22165957
[TBL] [Abstract][Full Text] [Related]
33. An ultra-sensitive DNA assay based on single-molecule detection coupled with hybridization accumulation and its application.
Sui B; Li L; Li L; Jin W
Analyst; 2011 Oct; 136(19):3950-5. PubMed ID: 21818488
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a Dual ALK/ROS1 Fluorescent In Situ Hybridization Test in Non-Small-cell Lung Cancer.
Ginestet F; Lambros L; Le Flahec G; Marcorelles P; Uguen A
Clin Lung Cancer; 2018 Sep; 19(5):e647-e653. PubMed ID: 29801706
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemistry, fluorescence in situ hybridization, and reverse transcription-polymerase chain reaction for the detection of anaplastic lymphoma kinase gene rearrangements in patients with non-small cell lung cancer: potential advantages and methodologic pitfalls.
Demidova I; Barinov A; Savelov N; Gagarin I; Grinevitch V; Stroiakovaski D; Popov M; Laktionov K; Gutorov S; Smolin A; Olshanskaya Y; Obukhova T
Arch Pathol Lab Med; 2014 Jun; 138(6):794-802. PubMed ID: 24878018
[TBL] [Abstract][Full Text] [Related]
36. ALK testing in lung adenocarcinoma: technical aspects to improve FISH evaluation in daily practice.
Martin V; Bernasconi B; Merlo E; Balzarini P; Vermi W; Riva A; Chiaravalli AM; Frattini M; Sahnane N; Facchetti F; Mazzucchelli L; Sessa F; Tibiletti MG
J Thorac Oncol; 2015 Apr; 10(4):595-602. PubMed ID: 25514802
[TBL] [Abstract][Full Text] [Related]
37. Detection of Epstein-Barr virus infection in gastric carcinomas using quantum dot-based fluorescence in-situ hybridization.
Peng J; Chen HL; Zhu XB; Yang GF; Zhang ZL; Tian ZQ; Pang DW
J Nanosci Nanotechnol; 2011 Nov; 11(11):9725-30. PubMed ID: 22413281
[TBL] [Abstract][Full Text] [Related]
38. Determination of HER2/neu status: a pilot study comparing HER2/neu dual in situ hybridization DNA probe cocktail assay performed on cell blocks to immunohistochemisty and fluorescence in situ hybridization performed on histologic specimens.
Hartman AK; Gorman BK; Chakraborty S; Mody DR; Schwartz MR
Arch Pathol Lab Med; 2014 Apr; 138(4):553-8. PubMed ID: 24678687
[TBL] [Abstract][Full Text] [Related]
39. Quantum dot optical encoded polystyrene beads for DNA detection.
Cao YC; Liu TC; Hua XF; Zhu XX; Wang HQ; Huang ZL; Zhao YD; Liu MX; Luo QM
J Biomed Opt; 2006; 11(5):054025. PubMed ID: 17092174
[TBL] [Abstract][Full Text] [Related]
40. Clinical Validation of Quantum Dot Barcode Diagnostic Technology.
Kim J; Biondi MJ; Feld JJ; Chan WC
ACS Nano; 2016 Apr; 10(4):4742-53. PubMed ID: 27035744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
